5,851 reports of this reaction
20.4% of all CENEGERMIN BKBJ reports
#1 most reported adverse reaction
EYE PAIN is the #1 most commonly reported adverse reaction for CENEGERMIN BKBJ, manufactured by Domp farmaceutici S.p.A.. There are 5,851 FDA adverse event reports linking CENEGERMIN BKBJ to EYE PAIN. This represents approximately 20.4% of all 28,659 adverse event reports for this drug.
Patients taking CENEGERMIN BKBJ who experience eye pain should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
EYE PAIN is a frequently reported adverse event for CENEGERMIN BKBJ, accounting for a significant proportion of all reports.
In addition to eye pain, the following adverse reactions have been reported for CENEGERMIN BKBJ:
The following drugs have also been linked to eye pain in FDA adverse event reports:
EYE PAIN has been reported as an adverse event in 5,851 FDA reports for CENEGERMIN BKBJ. This does not prove causation, but indicates an association observed in post-market surveillance data.
EYE PAIN accounts for approximately 20.4% of all adverse event reports for CENEGERMIN BKBJ, making it one of the most commonly reported side effect.
If you experience eye pain while taking CENEGERMIN BKBJ, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.